# FDA recall D-0320-2023

> **Sentara Infusion Services** · Class II · drug recall initiated 2022-12-27.

## Product

TPN (a) 115GM/AA, 215GM/DEX, 25GM/LIP 1150ML, (b)90GM/AA, 215GM/DEX, 25GM/LIP 1150ML, (c) TPN AA: 100GM DEX: 105GM 2700ML, (d) TPN AA: 100GM DEX: 105GM LIP: 45GM 2700ML, (e) TPN:  AA100GM ; DEX185GM ; LIP50GM IN 1500ML, (f) TPN: AA 150GM ; DEX 220GM ; LIP 45GM IN 2400 ml, (g) TPN: AA 60GM ; DEX 200GM ; LIP 30GM IN 1500 ml, Rx only, use with Curlin pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320

## Reason for recall

Lack of sterility assurance

## Distribution

Dispensed to Patients Nationwide.

## Key facts

- **Recall number:** D-0320-2023
- **Recalling firm:** Sentara Infusion Services
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-12-27
- **Report date:** 2023-02-22
- **Termination date:** 2026-02-20

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Chesapeake, VA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0320-2023

## Citation

> AI Analytics. FDA recall D-0320-2023. Retrieved 2026-06-24 from https://api.ai-analytics.org/recall/D-0320-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*